Orbimed Advisors as of Sept. 30, 2017
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 138 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 4.9 | $511M | 3.6M | 140.29 | |
| Biogen Idec (BIIB) | 4.9 | $510M | 1.6M | 313.12 | |
| Celgene Corporation | 4.7 | $489M | 3.4M | 145.82 | |
| Boston Scientific Corporation (BSX) | 3.7 | $391M | 13M | 29.17 | |
| Merck & Co (MRK) | 3.4 | $351M | 5.5M | 64.03 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $315M | 2.1M | 152.04 | |
| Puma Biotechnology (PBYI) | 2.8 | $291M | 2.4M | 119.75 | |
| Eli Lilly & Co. (LLY) | 2.5 | $263M | 3.1M | 85.54 | |
| Regeneron Pharmaceuticals (REGN) | 2.5 | $256M | 573k | 447.12 | |
| CIGNA Corporation | 2.3 | $237M | 1.3M | 186.94 | |
| Amgen (AMGN) | 2.2 | $234M | 1.3M | 186.45 | |
| Agilent Technologies Inc C ommon (A) | 2.2 | $234M | 3.6M | 64.20 | |
| Wright Medical Group Nv | 2.2 | $231M | 8.9M | 25.87 | |
| Aetna | 2.1 | $222M | 1.4M | 159.01 | |
| Clovis Oncology | 1.9 | $197M | 2.4M | 82.40 | |
| Incyte Corporation (INCY) | 1.9 | $196M | 1.7M | 116.74 | |
| Anthem (ELV) | 1.7 | $176M | 928k | 189.88 | |
| Clementia | 1.7 | $176M | 10M | 16.89 | |
| Array BioPharma | 1.7 | $174M | 14M | 12.30 | |
| Abbvie (ABBV) | 1.7 | $175M | 2.0M | 88.86 | |
| Loxo Oncology | 1.5 | $159M | 1.7M | 92.12 | |
| Gilead Sciences (GILD) | 1.5 | $156M | 1.9M | 81.02 | |
| Edwards Lifesciences (EW) | 1.4 | $152M | 1.4M | 109.31 | |
| Johnson & Johnson (JNJ) | 1.4 | $146M | 1.1M | 130.01 | |
| Immunomedics | 1.3 | $140M | 10M | 13.98 | |
| Beigene (ONC) | 1.3 | $136M | 1.3M | 103.46 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $128M | 1.1M | 117.49 | |
| Ascendis Pharma A S (ASND) | 1.2 | $122M | 3.4M | 36.25 | |
| Audentes Therapeutics | 1.1 | $116M | 4.1M | 28.01 | |
| Mylan Nv | 1.1 | $113M | 3.6M | 31.37 | |
| Jazz Pharmaceuticals (JAZZ) | 1.1 | $110M | 749k | 146.25 | |
| Select Medical Holdings Corporation (SEM) | 1.0 | $107M | 5.6M | 19.20 | |
| Thermo Fisher Scientific (TMO) | 1.0 | $101M | 534k | 189.20 | |
| Juno Therapeutics | 0.9 | $92M | 2.0M | 44.86 | |
| Ironwood Pharmaceuticals (IRWD) | 0.9 | $91M | 5.8M | 15.77 | |
| Pfizer (PFE) | 0.8 | $88M | 2.5M | 35.70 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $86M | 5.4M | 15.94 | |
| Illumina (ILMN) | 0.8 | $79M | 399k | 199.20 | |
| Shire | 0.7 | $77M | 500k | 153.14 | |
| Magellan Health Services | 0.7 | $76M | 883k | 86.30 | |
| Allergan | 0.7 | $77M | 374k | 204.95 | |
| Universal Health Services (UHS) | 0.7 | $74M | 669k | 110.94 | |
| UnitedHealth (UNH) | 0.7 | $74M | 380k | 195.85 | |
| Global Blood Therapeutics In | 0.7 | $74M | 2.4M | 31.05 | |
| Aerie Pharmaceuticals | 0.7 | $70M | 1.4M | 48.60 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $69M | 744k | 93.07 | |
| Medtronic (MDT) | 0.7 | $68M | 879k | 77.77 | |
| Bluebird Bio | 0.6 | $66M | 482k | 137.35 | |
| Intellia Therapeutics (NTLA) | 0.6 | $66M | 2.7M | 24.85 | |
| Bristol Myers Squibb (BMY) | 0.6 | $65M | 1.0M | 63.74 | |
| Allergan Plc pfd conv ser a | 0.6 | $65M | 88k | 737.82 | |
| Stryker Corporation (SYK) | 0.6 | $60M | 421k | 142.02 | |
| Intuitive Surgical (ISRG) | 0.6 | $59M | 56k | 1045.89 | |
| Achillion Pharmaceuticals | 0.6 | $59M | 13M | 4.49 | |
| Insmed (INSM) | 0.6 | $59M | 1.9M | 31.21 | |
| Gw Pharmaceuticals Plc ads | 0.5 | $57M | 561k | 101.49 | |
| Integra LifeSciences Holdings (IART) | 0.5 | $55M | 1.1M | 50.48 | |
| Mallinckrodt Pub | 0.5 | $55M | 1.5M | 37.37 | |
| Insys Therapeutics | 0.5 | $55M | 6.2M | 8.88 | |
| Viewray (VRAYQ) | 0.5 | $55M | 9.5M | 5.76 | |
| Kala Pharmaceuticals | 0.5 | $54M | 2.4M | 22.84 | |
| Galapagos Nv- (GLPG) | 0.5 | $53M | 524k | 101.75 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $50M | 6.4M | 7.75 | |
| Nevro (NVRO) | 0.4 | $45M | 495k | 90.88 | |
| eHealth (EHTH) | 0.4 | $44M | 1.8M | 23.89 | |
| Radius Health | 0.4 | $43M | 1.1M | 38.55 | |
| ImmunoGen | 0.4 | $42M | 5.5M | 7.65 | |
| Pieris Pharmaceuticals | 0.4 | $42M | 7.3M | 5.76 | |
| Synergy Pharmaceuticals | 0.4 | $40M | 14M | 2.90 | |
| Momenta Pharmaceuticals | 0.4 | $39M | 2.1M | 18.50 | |
| Dermira | 0.4 | $38M | 1.4M | 27.00 | |
| Spark Therapeutics | 0.4 | $38M | 430k | 89.16 | |
| Alpine Immune Sciences | 0.4 | $38M | 3.3M | 11.60 | |
| Selecta Biosciences | 0.3 | $34M | 1.8M | 18.25 | |
| Dimension Therapeutics | 0.3 | $32M | 5.4M | 6.00 | |
| Nabriva Therapeutics | 0.3 | $32M | 3.9M | 8.19 | |
| Glaukos (GKOS) | 0.3 | $28M | 837k | 33.00 | |
| Assembly Biosciences | 0.2 | $26M | 748k | 34.92 | |
| Synlogic | 0.2 | $25M | 1.3M | 19.02 | |
| Intercept Pharmaceuticals In | 0.2 | $22M | 386k | 58.04 | |
| Dbv Technologies S A | 0.2 | $22M | 513k | 42.44 | |
| Obseva Sa | 0.2 | $21M | 2.6M | 8.14 | |
| Natera (NTRA) | 0.2 | $20M | 1.6M | 12.89 | |
| Envision Healthcare | 0.2 | $20M | 441k | 44.95 | |
| Sinovac Biotech | 0.2 | $19M | 2.7M | 7.05 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $17M | 968k | 17.90 | |
| Neurocrine Biosciences (NBIX) | 0.2 | $18M | 285k | 61.28 | |
| Zai Lab (ZLAB) | 0.2 | $18M | 658k | 27.00 | |
| Xencor (XNCR) | 0.2 | $17M | 747k | 22.92 | |
| Novo Nordisk A/S (NVO) | 0.1 | $16M | 330k | 48.15 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $16M | 1.9M | 8.19 | |
| Cti Biopharma | 0.1 | $16M | 5.0M | 3.19 | |
| Hca Holdings (HCA) | 0.1 | $15M | 187k | 79.59 | |
| Coherus Biosciences (CHRS) | 0.1 | $14M | 1.1M | 13.35 | |
| Invitae (NVTAQ) | 0.1 | $14M | 1.5M | 9.37 | |
| Steadymed | 0.1 | $14M | 4.2M | 3.35 | |
| Wright Medical Group Rtsn V | 0.1 | $14M | 8.7M | 1.55 | |
| Novus Therapeutics | 0.1 | $13M | 2.5M | 5.21 | |
| NuVasive | 0.1 | $12M | 221k | 55.46 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $12M | 15M | 0.81 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $11M | 1.8M | 6.27 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $11M | 2.3M | 4.85 | |
| Argenx Se (ARGX) | 0.1 | $11M | 500k | 22.61 | |
| Heron Therapeutics (HRTX) | 0.1 | $11M | 650k | 16.15 | |
| Verona Pharma Plc ads (VRNA) | 0.1 | $10M | 667k | 15.35 | |
| Newlink Genetics Corporation | 0.1 | $9.0M | 881k | 10.18 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $8.8M | 1.7M | 5.04 | |
| Teva Pharmaceutical Industries (TEVA) | 0.1 | $7.1M | 406k | 17.60 | |
| Alkermes (ALKS) | 0.1 | $7.4M | 145k | 50.84 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $6.8M | 150k | 45.36 | |
| Fluidigm Corporation convertible cor | 0.1 | $7.4M | 10M | 0.74 | |
| Aeglea Biotherapeutics | 0.1 | $7.2M | 1.5M | 4.93 | |
| Deciphera Pharmaceuticals | 0.1 | $7.5M | 394k | 18.99 | |
| Halozyme Therapeutics (HALO) | 0.1 | $6.1M | 350k | 17.37 | |
| Redhill Biopharma Ltd cmn | 0.1 | $6.1M | 565k | 10.81 | |
| Crispr Therapeutics (CRSP) | 0.1 | $6.7M | 372k | 17.87 | |
| Zimmer Holdings (ZBH) | 0.1 | $5.7M | 49k | 117.08 | |
| Glycomimetics | 0.1 | $4.7M | 338k | 13.99 | |
| Seres Therapeutics | 0.1 | $4.7M | 295k | 16.04 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $5.1M | 437k | 11.70 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.1 | $5.5M | 7.0M | 0.79 | |
| Sierra Oncology | 0.1 | $5.7M | 3.7M | 1.55 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $2.9M | 2.2M | 1.33 | |
| Valeant Pharmaceuticals Int | 0.0 | $2.8M | 195k | 14.33 | |
| Marinus Pharmaceuticals | 0.0 | $3.3M | 568k | 5.87 | |
| Otonomy | 0.0 | $2.1M | 644k | 3.25 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $1.9M | 635k | 2.95 | |
| Orexigen Therapeutics Inc note 2.750%12/0 | 0.0 | $2.0M | 5.2M | 0.39 | |
| Biolinerx Ltd-spons | 0.0 | $1.2M | 1.0M | 1.12 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $560k | 500k | 1.12 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $600k | 500k | 1.20 | |
| Affimed Therapeutics B V | 0.0 | $735k | 327k | 2.25 | |
| Noveliontherapeuti.. | 0.0 | $703k | 100k | 7.03 | |
| Alimera Sciences | 0.0 | $338k | 250k | 1.35 | |
| Versartis | 0.0 | $123k | 50k | 2.46 | |
| Xtant Med Holdings | 0.0 | $342k | 475k | 0.72 | |
| Roka Bioscience | 0.0 | $147k | 202k | 0.73 | |
| Medigus Ltd sponsord | 0.0 | $134k | 60k | 2.23 |
